[Autoimmune myelofibrosis with dermatomyositis].
We report a second observation of autoimmune myelofibrosis associated with an inflammatory myositis in a 30-year-old female. The links between myelofibrosis and autoimmunity are discussed.
Sahali
S
S
Service de médecine interne, CHU de Bicêtre, AP-HP, 78, rue du Général-Leclerc, 94275 Le-Kremlin-Bicêtre, France.
Ghosn
J
J
Lazure
T
T
Goujard
C
C
Delfraissy
J-F
JF
Lambotte
O
O
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001327:Autoimmune Diseases; D001706:Biopsy; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003882:Dermatomyositis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000150:complications* / Q000276:immunology; D011644:Puerperal Disorders; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D005938:Glucocorticoids; D009173:Mycophenolic Acid; D011241:Prednisone